+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Genetic imprinting in schizophrenia

Genetic imprinting in schizophrenia

Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 706 15

A growing body of evidence suggests that the 5HT2A receptor (5HT2AR) may play a role in the aetiology and treatment of psychiatric disorders. Some but not all of the numerous 5HT2AR studies have reported association between schizophrenia and the silent 5HT2A 102 T/C genetic polymorphism. Epigenetic factors, such as RNA splicing, RNA editing and genetic imprinting, may be responsible for some of these contradictory findings and these factors can have marked effects on phenotypic variation. We are testing the hypothesis that polymorphic imprinting of the 5HT2AR gene1 and also of other gene candidates, such as 5HT2CR and COMT, may be frequent enough to confound current genetic paradigms.) Initially expression of the 5HT2AR T102 and C102 alleles in the prefrontal cortex of schizophrenia cases (n=10) and normal controls (n=8) have been compared. All subjects were heterozygous for this polymorphism. When the ratios of expression levels of each allele (T/C) were compared between the patient and control groups, no significant differences were detected. However, one individual with schizophrenia exhibited complete imprinting of the C102 allele. A previous study in 18 controls reported 4 individuals with complete imprinting using this marker1, indicating that 5HT2AR gene imprinting is highly variable. Studies of 5HT2C and COMT are ongoing. These preliminary findings demonstrate that interpretations based solely on the genotype of subjects would be misleading, and that gene expression levels should also be considered.)1. Bunzel R, Blumcke I, Cichon S et al. Mol Brain Res 1998; 59, 90-92.

(PDF emailed within 1 workday: $29.90)

Accession: 034983803

Download citation: RISBibTeXText

Related references

Imprinting and anticipation. Are they relevant to genetic studies of schizophrenia?. British Journal of Psychiatry 164(5): 619-624, 1994

Substantial genetic link between IQ and working memory: implications for molecular genetic studies on schizophrenia. the European twin study of schizophrenia (EUTwinsS). American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 162b(4): 413-418, 2013

A human imprinting centre demonstrates conserved acquisition but diverged maintenance of imprinting in a mouse model for Angelman syndrome imprinting defects. Human Molecular Genetics 15(3): 393-404, 2005

Imprinting on chromosome 20: tissue-specific imprinting and imprinting mutations in the GNAS locus. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics 154c(3): 377-386, 2010

Anticipation and imprinting in schizophrenia. Biological Psychiatry. 42(9): 760-766, 1997

Prospects for research on schizophrenia. IV. Genetic and environmental factors. Genetic models for schizophrenia. Neurosciences Research Program Bulletin 10(4): 406-419, 1972

Anticipation and imprinting in familial schizophrenia. Neuroscience Research Supplement 0(21): S301, 1997

Imprinting of the 5-HT2A receptor in schizophrenia. American Journal of Medical Genetics 122B(1): 177, September 15, 2003

Anticipation and imprinting in Spanish families with schizophrenia. Acta Psychiatrica Scandinavica. 97(5): 343-350,, 1998

Investigation of 5-HT2A differential expression and imprinting in schizophrenia. American Journal of Medical Genetics 96(4): 561, August 7, 2000

Schizophrenia, cancer and imprinting: early nutritional influences. British Journal of Psychiatry 188: 394-394, 2006

Effect of blood serum from patients with schizophrenia on imprinting. Soobshcheniya Akademii Nauk Gruzinskoi SSR 98(1): 217-220, 1980

Inhibition of imprinting under the influence of blood serum from schizophrenia patients. Byulleten' Eksperimental'noi Biologii i Meditsiny 91(6): 16-17, 1981

Paternal factors and schizophrenia risk: de novo mutations and imprinting. Schizophrenia Bulletin 27(3): 379-393, 2001